Obesity

Vincentage to chase Lilly to China regulators after obesity win

Vincentage's oral GLP-1 has been tied to weight loss of 12.4% over a year, setting up the biotech to pursue Lilly’s orforglipron to Chinese regulators

James Waldron May 18, 2026 9:23am

Why Lexicon is in ‘good shape to go crazy’: CEO

May 13, 2026 10:50am

‘No change’ for CagriSema as Novo ditches single-chamber device

May 6, 2026 4:40am

Boehringer links dual agonist to 16.6% weight loss in phase 3

Apr 28, 2026 4:00am

Endoscopic procedure can help slow weight rebound from GLP-1s

Apr 27, 2026 8:48am

Roche CEO gives 3 reasons for sitting out Big Pharma M&A spree

Apr 23, 2026 5:18am